High proportion of isolates of Campylobacter in humans are resistant to ciprofloxacin, tetracyclines
MONDAY, Feb. 15, 2016 (HealthDay News) — Bacteria in humans, food, and animals continue to show resistance to commonly used antimicrobials, according to a report published online Feb. 11 by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC).
The EFSA and ECDC jointly analyzed data on antimicrobial resistance in zoonotic and indicator bacteria in 2014, which were submitted by 28 European Union (EU) member states.
The researchers found that high proportions of Salmonella isolates from humans were resistant to ampicillin, sulfonamides, and tetracyclines, while resistance to third-generation cephalosporins and fluoroquinolones was generally low. Salmonella and Escherichia coli isolates from broilers, fattening turkeys, and meat thereof frequently had resistance to fluoroquinolones, tetracyclines, and sulfonamides, but rarely had resistance to third-generation cephalosporins. In Salmonella and Escherichia coli from poultry and meat thereof, low levels of resistance to colistin were observed. A high to very high proportion of isolates of Campylobacter in humans were resistant to ciprofloxacin and tetracyclines; low to moderate resistance was seen to erythromycin. Co-resistance to critically important antimicrobials in human and animal isolates was typically rare.
“Every year in the EU, infections caused by antimicrobial resistance lead to about 25,000 deaths — but the threat is not confined to Europe,” Vytenis Andriukaitis, the EU Commissioner for Health and Food Safety, said in a statement. “This is a global problem that requires a global solution.”
Copyright © 2016 HealthDay. All rights reserved.
